MILLENNIUM MANAGEMENT LLC
Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.
CIK 1273087
NEW YORK, NY
Position in CRBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$107,288
-$904,954 QoQ
Shares Held
11,438
-89.4% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 106 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBP Over Time
Shares Held
Position Value (USD)
Derivatives in CRBP
reported options exposure · as of Sep 30, 2024CallValue
$412,600
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. CRBP ranks #302 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CRBP
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,288 | 11,438 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,012,242 | 107,800 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $301,709 | 37,065 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,725,826 | 136,429 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,098,217 | 159,162 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $539,533 | 101,607 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,562,505 | 386,653 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $412,600 | 20,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $2,119,753 | 102,751 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,934,617 | 241,649 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,749,154 | 324,902 | Shares | Sole | 2024-05-15 | |
| 2022-09-30 | $1,911 | 11,585 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $87,927 | 348,917 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $262,834 | 494,050 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $413,775 | 671,713 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $689,630 | 676,108 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,274,647 | 1,242,977 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $22,356 | 17,885 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $4,028,810 | 480,192 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $189,740 | 36,210 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||